Conjugation of universal, functionally de-targeted OneAAVTM capsid provides on-demand specificity and scalabilityto address ...
SK pharmteco today announced a strategic partnership with Axle Informatics and the National Institutes of Health (NIH) to ...
High-throughput virology, design of experiments, and small-molecule production enhancers optimize yield and increase ...
This review examines how CAR-T cell therapy is expanding beyond blood cancers into solid tumors, autoimmune diseases, chronic ...
Mission Bio, the leader in single-cell multiomics, published research in Molecular Therapy Advances showing that their ...
Latus Bio has secured $97 million in Series A financing, including a $43 million extension led by 8VC, to advance and broaden access to its gene therapies. The funding will support clinical milestones ...
Jonathan B. Jassey, DO, is a private pediatrician at Bellmore Merrick Medical. Dr. Jassey also specializes in treating ADHD, anxiety, depression, OCD, autism and other mental health issues. Viral ...
Dyno Therapeutics, Inc., a genetic technologies company applying artificial intelligence (AI) to solve the grand challenge of in vivo gene delivery, today announced that it will host a Scientific ...
IV delivery of VY1706, a CNS penetrant AAV gene therapy for AD, demonstrates compelling pharmacology and safety in a 3-month ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results